InvestorsHub Logo

MontanaState83

05/09/20 8:49 AM

#272379 RE: rosemountbomber #272368

I would hope profits would not be part of the equation. Amarin’s goal, the end game, was always the CV indication. Jumping thru the Marine and Anchor hoops was part of the process to enable funding a massively expensive CV study (RIt). Funding Reduce It was a major impediment to profitability.

Script growth demonstrated success (IMHO) as the trajectory has been upward ever since Marine

Bill B

05/09/20 9:43 AM

#272395 RE: rosemountbomber #272368

Define success. Minus the cost of the reduce it trial mandated by the FDA for the new label would they have been profitable selling only under the Marine patents?

Jvee

05/09/20 9:56 AM

#272400 RE: rosemountbomber #272368

The rate of script and revenue growth are a clear indication that the product is a success. Profitability will follow and it is easy to demonstrate that they are on that path.